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Abstract
Background: The lymphatic filarial parasite Brugia timori occurs only in eastern Indonesia where it causes high morbidity.
The absence of an animal reservoir, the inefficient transmission by Anopheles mosquitoes and the high sensitivity to DEC/
albendazole treatment make this species a prime candidate for elimination by mass drug administration (MDA).
Methodology/Principal Findings: We evaluated the effect of MDA using DEC and albendazole on B. timori and soil
transmitted helminths (STH) in a cross-sectional study of a sentinel village on Alor Island annually over a period of 10 years.
Pre-MDA the microfilaria (MF) prevalence was 26% and 80% of the residents had filaria-specific IgG4 antibodies. In 2010, 34
months after the 6th round of MDA, MF and antibody rates were only 0.17% and 6.4%, respectively. The MDA campaign had
also a beneficial effect on STH. Baseline prevalence rates for Ascaris, hookworm and Trichuris were 34%, 28%, and 11%,
respectively; these rates were reduced to 27%, 4%, and 2% one year after the 5th round of MDA. Unfortunately, STH rates
rebounded 34 months after cessation of MDA and approached pre-MDA rates. However, the intensity of STH infection in
2009 was still reduced, and no heavy infections were detected.
Conclusions/Significance: MDA with DEC/albendazole has had a major impact on B. timori MF and IgG4 antibody rates,
providing a proof of principle that elimination is feasible. We also documented the value of annual DEC/albendazole as a
mass de-worming intervention and the importance of continuing some form of STH control after cessation of MDA for
filariasis.
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Lymphatic filariasis (LF) has been targeted by the World Health
Organization for global elimination by the year 2020 [1]. During
the years 2000 to 2009 the Global Program to Eliminate
Lymphatic Filariasis (GPELF) has provided .2.8 billion treat-
ments with anti-filarial drugs to a minimum of 885 million
individuals living in 53 endemic countries [2,3]. The recom-
mended oral regimen for use in Asia is annual mass drug
administration (MDA) with diethylcarbamazine (DEC, 6 mg/kg
body weight) combined with albendazole (alb, fixed dose of
400 mg) [1]. We have previously published a preliminary report
on the impact of two annual rounds of MDA on brugian filariasis
in Alor Island in Eastern Indonesia [4]. Other studies have shown
that BmR1 rapid antibody test [5,6] is a sensitive marker for
detecting brugian filariasis in populations. However, more data are
required to validate antibody testing as a tool for monitoring the
impact of MDA on filariasis in populations.
Studies on bancroftian filariasis in Egypt concluded that five
rounds of MDA may have been sufficient to eliminate the infection
in most implementation units in that country [7]. Declines in rates
of infection markers such as circulating filarial antigenemia and
microfilaremia were accompanied by diminished rates of anti-
filarial IgG4 antibodies in school children. Similar findings were
reported after three rounds of MDA in Papua New Guinea, where
antibody prevalence decreased faster in children than in adults [8].
Anti-filarial antibodies are a marker for past, present or exposure
to filarial infections. Antibody clearance tends to occur faster after
treatment in children than in adults, since children tend to have
shorter term exposure and lighter infections. Therefore, adults
may have persistent antibodies years after effective therapy [9,10].
Less is known about antibody clearance after treatment of brugian
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filariasis, and research is needed to determine the dynamics of this
clearance with different antibody assays.
Mass drug administration of DEC combined with alb has an
additional beneficial effect in reducing prevalence and intensity of
infection with intestinal helminths such as Ascaris lumbricoides,
hookworms and Trichuris trichiura [4,11,12]. Unfortunately, most
studies have evaluated the effect of MDA on intestinal helminths
after only one or two treatment rounds in school-aged children,
and data on the impact of multiple rounds after population-based
MDA used in filariasis elimination programs are lacking.
Pilot studies in 2001 detected a high prevalence of B. timori
infection and filariasis-associated morbidity in the highlands of
Alor island [13]. We initiated treatment trials and worked with
local health officials to develop an MDA program on the island.
We reported the results of the first two rounds of MDA in prior
publications [4,14,15]. The objective of the present paper is to
evaluate the impact of six annual rounds of MDA on brugian
filariasis and on soil-transmitted helminths (STH) infections in a
sentinel village on Alor and also report the results collected over 3
years following the last round of MDA.
Methods
Study area
The study was performed in Mainang village (population in
2002 approximately 1,500) on Alor island (East Nusa Tenggara
Timor, Indonesia). Details of the study site have been published
elsewhere [4,13]. Conditions in Alor and in Mainang changed
over the course of the study. For example, the island received
considerable financial support following a major earthquake in
2004 which improved infrastructure and living conditions. Bed net
use has increased and the hygienic conditions have improved
during the study period. However, Alor district remains one of the
poorest districts of Indonesia.
Sample collection
Over the 10 year study period (Fig. 1) the study population of
the three study sectors of the village increased from about 1,500 to
about 1,800. Annual surveys collected samples from 600–750
residents, which comprised 33%–50% of the eligible population.
Children younger than 3 years and severely ill persons were
considered not eligible and excluded from the surveys. Almost all
residents were examined at least once over the study period, while
most individuals were examined twice or three times. However,
only about 20% of the population participated in all 10 surveys.
The study population and the sample collection procedure were
described in detail in earlier reports [4,13]. Briefly, sex, age and
name were noted; after a brief clinical examination 3 ml venous
blood was collected between 7.00 p.m. and 11 p.m. One labeled
stool container was provided to each individual participating in the
blood collection, and these were collected one day later by local
health workers.
Ethics statement
The study was approved by the ethical board of the Faculty of
Medicine, University of Indonesia, Jakarta and the institutional
review boards at Bernhard Nocht Institute for Tropical Medicine
in Hamburg, Germany, as well as at Washington University
School of Medicine in St. Louis, USA. Since written consent is not
consistent with cultural norms on Alor island, oral informed
consent was obtained from all adults or, in case of children, from
their parents. The ethical board of the University of Indonesia and
the institutional review boards in Germany and the USA approved
the use of oral consent. The participant’s oral consent was noted
on the survey questionnaire.
Figure 1. Schematic overview of the study design. In 2001 microfilaria and anti-filarial IgG4 baseline surveys were performed and MF positive
and lymphoedema patients were selectively treated. Baseline data on STH infections was collected in 2002, and the village was re-examined for filarial
infections at that time just prior the first round of MDA with diethylcarbamazine plus albendazole. Subsequent post-MDA surveys were performed 9
to 11 months after each round of MDA. MDA was continued until 2007, when the last (6th) round of MDA was provided and annual follow-up surveys
were continued until 2010.
doi:10.1371/journal.pntd.0002586.g001
Author Summary
The impact of six annual rounds of mass drug administra-
tion (MDA) using DEC combined with albendazole on
brugian filariasis and soil-transmitted helminths (STH) was
evaluated. Microfilaria rates of B. timori dropped quickly
after MDA and were below 1% for 34 months after
stopping intervention when the study ended. The preva-
lence of filarial-specific IgG4 antibodies in the community
as measured by the Brugia Rapid test was about 80%
before MDA and dropped slowly to about 6% at the end of
the study period. MDA had also a beneficial effect on STH,
especially on hookworm, but prevalence rates rebounded
34 months after cessation of MDA and quickly approached
pre-control levels, while infection intensity was still
reduced. Our study indicated that B. timori infection can
be eliminated by DEC/albendazole MDA and that the anti-
filarial IgG4 rate in the community significantly declines
over time. While lymphatic filariasis (LF) MDA can be
considered as a powerful general deworming campaign,
STH infection rates rebound quickly and a supplementary
control strategy is needed after LF MDA is ceased.
Impact of MDA on Brugia and Soil-Transmitted Helminths
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Mass drug administration
Community-based MDA using a single dose of DEC and alb
was performed by the local District Health Authority. The local
primary health care center (‘‘Puskesmas’’) trained a number of
villagers (cadres) that were responsible for distributing anthemin-
tics to 100 to 200 residents in their neighbourhood by directly
observed treatment. Pregnant or breastfeeding women, children
younger than two years of age, or persons suffering from acute or
severe illnesses were not eligible for treatment. In most cases
cadres knew which community members were ineligible (pregnant
or lactating women), but they used a short interview to assess
eligibility for others. Medications were dosed based on age rather
than on weight, as previously described [4]. The District Health
Authority reported coverage rates (number of distributed doses per
number of residents) between 75% and 85% for all years of MDA
(Paul Manoempil pers. commun.). In addition, an independent
survey of compliance in five villages on Alor in the first year of the
MDA program documented a compliance rate of about 88% [16].
Compliance with MDA was defined as the percentage of the
eligible population that reported that they had swallowed the
drugs. MDA was discontinued following the treatment round in
2007 (Fig. 1), because MF rates had fallen below 1% in the
previous 2 years and because no funds were available at that time
to continue MDA or to perform a more extensive assessment
according to the WHO guidelines at that time [17].
Assessment of microfilariae and helminth eggs
Microfilaraemia was determined by membrane filtration of 1 ml
of night blood collected in EDTA as previously described [4].
A single stool sample was examined for intestinal helminths
from each individual surveyed. The Harada-Mori hatching test
was used to detect living hookworm larvae as described previously
[4]. Based on larval morphology and PCR, the predominant
hookworm species in Alor was found to be Necator americanus
(Supali and co-workers, unpublished results). Part of the stool
samples was preserved in the field using 4% formaldehyde and
examined in the laboratory in Jakarta using the formalin/ether-
enrichment method within 2 months of collection.
The Kato-Katz method was used to assess STH infections in the
baseline survey in 2002 and again in 2009, 22 months after the 6th
(and final) round of MDA (Fig. 1). A single Kato Katz smear of
41 mg of stool was performed to determine STH egg counts and
to classify egg densities according to WHO guidelines as light,
moderate and heavy intensity infection [18]. Stool samples were
examined (Kato Katz, Harada-Mori) or preserved (formalin/
ether-enrichment) within 18 h of distribution of stool containers.
For tests other than the Kato-Katz, the numbers of helminth eggs
or hookworm larvae were arbitrarily scored as follows: low density
(1–10 eggs per slide or 1–50 hookworm larvae per plastic bag
containing approximately 0.5 g stool), moderate density (11–100
eggs or 51–500 larvae) or high density (more than 100 eggs or 500
larvae).
Detection of anti-filarial IgG4 antibodies
Specific IgG4 antibodies were detected using the dipstick
version of the Brugia Rapid test (Malaysian Bio-Diagnostics
Research Sdn Bhd, Bangi, Malaysia). Tests were performed in the
field using 25 ml of plasma as previously described [19].
Statistical analysis
The total number of subjects included in the surveys was
calculated using a 95% confidence level and a confidence interval
of less than 3%. The chi-square test was used to assess the
significance of differences in infection prevalence rates between
different groups or between study periods, while the Mann-
Whitney U test was used to assess infection intensity data. A p
value is regarded as significant if less than 0.05. All statistical
analyses were done using the SPSS software package (IBM).
Results
1. Effects of MDA on microfilaremia
Changes in microfilaremia prevalence are shown in Figure 2A.
MF rates fell from a baseline of 26% to less than 1% after round
4, and this decrease was maintained for the duration of the study
including the period following cessation of MDA. Only 5 MF-
positive individuals were detected among 737 individuals tested
one year after the 6th round of MDA. Three females (18, 19 and
47 years old) and two males (19 and 26 years old) had microfilaria
densities of 1356, 63, 6, 66, and 311 MF/ml respectively. The
two men were long-term visitors from another village who
reported that they had never received treatment. The three
females had participated in the pre-treatment blood collection,
and their MF counts at that time were 88, 2456 and 333MF/ml,
respectively. Two of the women had not regularly participated in
the surveys, but one was examined annually and was found to be
MF-positive during all examinations. In 2009 and 2010, 22 and
34 months after the 6th and last round of MDA, we examined a
total of 668 and 598 persons, respectively. Only one woman was
found to be MF-positive with 192 MF/ml and 115 MF/ml,
respectively. It was the same young lady who had been found to
be MF-positive all the years before. At first she claimed to have
regularly participated in MDA, but later she admitted that she
had not taken the medicines after the first treatment round
because she had experienced adverse events that included high
fever and severe headache.
2. Effects of MDA on anti-filarial IgG4 antibodies
We used the Brugia Rapid dipstick test as a marker for ongoing
or prior infection, because there is no adult worm antigen
detection test for Brugia spp. This test employs a recombinant B.
malayi antigen (BmRI) that has been extensively studied [19].
Antibody test results are shown in Figure 2B. Briefly, the antibody
rate decreased from 80% at baseline to a rate of 6.4% in 2010.
There was no significant difference between antibody prevalence
rates in male and female subjects all through the study. As
reported previously, antibody rates were high (about 80%) in all
age groups in 2001 [6]. In 2010 the antibody rates had strongly
declined. The rates varied with age (4.9% for subjects less than 21
years of age versus 8.7% for older subjects) (Fig. 3). However, this
difference between the two age groups was not significant. WHO
now recommends transmission assessment surveys (TAS) to
support decisions to stop MDA. The TAS are designed to
systematically sample school-aged children within an evaluation
unit [20]. In the absence of a rapid antigen test for Brugia, antibody
rates in school-aged children are used as the indicator for TAS.
Therefore, we analysed the decline of the filarial antibody rate as
determined by Brugia Rapid in pre-school and primary school-
aged children (Table 1). While the positive test rate for Brugia
Rapid in children aged between 3 and 10 years dropped rapidly
following MDA, the prevalence and the upper 95% confidence
limit dropped below 5% and 10%, respectively, for the first time in
2009, 22 months after the last round of MDA. In 2009 the
majority of children aged between 3 and 10 years were born after
the initiation of MDA, but many of these children might have
been exposed to B. timori during the early years of the MDA
program.
Impact of MDA on Brugia and Soil-Transmitted Helminths
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Figure 2. A Prevalence rates with 95% confidence intervals for Brugia timori microfilaraemia in Mainang village before and after
MDA with DEC/albendazole. Selective treatment of microfilaraemics and lymphedema patients was performed after the baseline survey in 2001.
The first round of MDA was distributed following the survey in 2002, and the last (6th) round of MDA was distributed after the 2007 survey was
performed. MDA coverage rates ranged between 75 and 85%. B Prevalence rates with 95% confidence intervals for anti-filarial antibodies as assessed
by the Brugia Rapid test. Since only selective treatment was performed in 2001, no Brugia Rapid tests were performed on the samples collected in
2002.
doi:10.1371/journal.pntd.0002586.g002
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The relationship between antibody and MF rates varied
considerably during the study period (compare Fig. 2A and B).
The antibody to MF ratio was 3.1 at baseline, but increased
dramatically after MDA. This means MF rates fell more rapidly
after MDA than antibody rates. For this reason, it is not possible to
use antibody rates to estimate MF prevalence rates following MDA.
3. Prevalence of soil transmitted helminths
Ascaris prevalence rates varied considerably during the study
period (Fig. 4A). The lowest prevalence of 18% was detected in
2006 after 4 rounds of MDA. In 2010, 34 months after the last
round of MDA, the prevalence (45%) was significantly higher than
the baseline prevalence (34%) prior to MDA (p,0.01).
In contrast, the hookworm prevalence rates decreased from 28%
at baseline to 13% after the first round of MDA and continued to
decrease to 0.7% in 2006 (Fig. 4B). The hookworm prevalence rates
were determined all through the study period by two independent
methods, formalin/ether enrichment and the Harada Mori
hatching test, which increases the overall sensitivity. Hookworm
rates rebounded to 7% at 34 months after the last MDA.
The first two rounds of MDA had little impact on the Trichuris
prevalence rate (baseline 9.4%), but this decreased dramatically to
less than 1% after the third round (Fig. 4C). The lowest rate (0.7%)
was observed after the last round of MDA in 2006; this slowly
increased after MDA ended to 7% in 2010. Interestingly, STH
infection rates were similar for male and female subjects (p.0.05%),
and there were no significant differences in age specific infection
rates in 2002 prior to MDA as well as in 2010 (p.0.5%).
4. Intensity of soil transmitted helminth (STH) infections
Infection intensities (by Kato-Katz) were assessed before MDA
in 2002 and in 2009, 22 months after the 6th round of MDA. As an
aside, infection intensities determined by Kato Katz were
Figure 3. Prevalence rates with 95% confidence intervals for antifilarial antibodies by age group as assessed by the Brugia Rapid
test. Baseline data for 2001 (prior to MDA) are shown with black bars should be compared with data from 2010 (black bars) (about 34 months after
the 6th and final round of MDA).
doi:10.1371/journal.pntd.0002586.g003
Table 1. Prevalence rates with 95% confidence intervals for
anti-filarial antibodies based on the Brugia Rapid test in
children aged between 3 and 10 years of age prior to MDA
(2001) and after one or more rounds of MDA.
Year N examined % Brugia Rapid Positive 95% CI
2001 120 82.0 75.1–88.8
2003 243 39.1 32.9–45.2
2004 202 41.1 34.3–47.9
2005 164 22.6 16.2–29.0
2006 138 13.0 7.4–18.6
2007 119 6.7 2.2–11.2
2008 115 13.9 7.4–20.2
2009 103 3.9 0.2–7.6
2010 116 4.9 0.6–8.0
The last round of MDA was performed in 2007. Since only selective treatment of
MF carriers was performed in 2001, no Brugia Rapid tests were performed on
the samples collected in 2002.
doi:10.1371/journal.pntd.0002586.t001
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generally consistent with informally scored infection intensities
obtained by the ether enrichment and Harada Mori methods.
MDA has shifted the frequency distributions of STH intensities
so that fewer subjects had heavy infections in 2009 than in 2002,
and these data are summarized in Figure 5. For example, infected
subjects in 5 of the 6 age groups had geometric mean of Ascaris
infection intensities in the moderately high range (between 5,000
and 49,000 eggs per gram [epg] according to WHO criteria) in
2002, and the geometric mean egg count in all infected subjects
was 15,000 epg. In 2009, three age groups had geometric mean
egg counts in the moderately high infection intensity range; the
geometric mean count for all infected subjects was 6,500 epg,
which represented a 57% reduction from the baseline value
(Fig. 5A).
Similar results were obtained for intensities of hookworm
infection (Fig. 5B). Adults aged 21 to 50 years with hookworm
infections had geometric mean egg counts in the high range
(.4,000 epg) in 2002, while children and adolescents had
geometric mean counts in the moderately high range (2,000–
3,999 epg), while other age groups had moderate mean infection
intensities. In 2009, no age group had geometric mean epg in the
high range, while moderate range geometric mean counts were
only seen in children less than 10 years of age and in adults in the
41–50 years age group. Geometric mean egg counts for T. trichiura
in 2009 were not significantly different from those in 2002, and
they tended to be low in all age groups at both time points (range
48–164 epg). However, only relatively few Trichuris infections were
assessed in 2009 quantitatively.
Discussion
We have studied the dynamics of helminth infection during and
for up to 34 months after six rounds of annual MDA using DEC
combined with albendazole in one sentinel village in eastern
Indonesia. The MF rate fell to less than 1% in 2006, and this
declined further to 0.17% in 2010 when the study ended. MDA
rapidly reduced MF counts in the population. We would have
detected fewer MF carriers if we had used thick blood smears for
MF detection according to WHO guidelines instead of the more
sensitive membrane filtration method [21]. In 2009 and 2010 only
a single MF positive individual was detected. This individual is an
example for systematic non-compliance with treatment because of
the fear of adverse events. The contribution of a single MF positive
person to the transmissions cycle appeared to be negligible because
no new MF positive individuals were found. Anti-filarial antibody
rates in the general population fell from 80% in 2001 to 6.4% in
2010. The antibody rate in children and young adults less than 21
years of age in 2010 was 4.9%. These results suggest that MDA
interrupted transmission of B. timori infection in Mainang village.
Since the MF rate in 2006 (after the 4th round of MDA) was
below 1% and remained below this threshold for the next 2 years,
the District Health Authority decided to stop MDA in 2008 due to
financial constraints. When external funding became available, a
TAS was performed in the entire district (Alor and Pantar islands)
in 2009 and in 2011 according to WHO guidelines [17,20]. The
district passed the TAS in both years, and this suggests that the
decision to stop MDA in 2008 was valid (Supali and co-workers,
unpublished results).
Analysis of anti-filarial IgG4 antibody rates over the 10 year
study period of the study showed that this rate has declined more
slowly than the MF rate following MDA. Current guidelines
recommend testing for antibody in children as a tool for detecting
ongoing transmission of brugian filariasis [10,21]. Our study
showed that IgG4 antibody rates as determined by Brugia Rapid
declined in children as well as in adults and eventually reached
very low levels some nine years after initiation of MDA and after
six annual rounds of MDA. The fact that a few children aged #10
years in 2010 had positive antibody tests can be explained by the
high antibody rate in young children in 2001 and the fact that it
takes several rounds of MDA to interrupt transmission of B. timori
[6]. The observation that it took 6 rounds of MDA and additional
22 months until the filarial antibody rate as determined by the
Brugia Rapid test dropped below 5% (upper 95% confidence limit
10%) in children aged between 3 and 10 years suggests that the
antibody rate is a sensitive marker for previous exposure to B.
timori. While all examined children in that age group were
constantly MF negative following the first two rounds of MDA, the
antibody prevalence dropped quickly but remained higher than
2% for the entire study period. A target of 2% antigen prevalence
is used for TAS inW. bancrofti areas [20]. It is possible that a higher
threshold of antibody prevalence is needed for TAS in Brugia areas.
However, Alor district as evaluation unitis endemic for B. timori
and W. bancrofti and passed the TAS in 2009 and in 2011 (one year
after conclusion of the present study) using antibody and antigen
tests (Supali et al, unpublished results) despite the fact that one
primary school in Mainang village was included in the surveys,
In order to use antibody rates in the general population as a
marker for evaluation of an MDA program, frequent follow-ups
are necessary to assess the decline of antibody prevalence over
time. It is likely that antibody rates would increase if transmission
resumes in the area, but this can only be assessed if longitudinal
antibody data are available for the study area. Moreover, the
Brugia Rapid test has already been employed to assess the success
Brugia malayi elimination from parts of the Republic of Korea [22].
The benefits of MDA using DEC combined with albendazole
beyond LF elimination have been extensively discussed previously
[23,24]. However, field data on the effects of MDA on STH are
limited since most programs in Africa use ivermectin instead of
DEC, and results are often available only for one or two rounds of
MDA. In addition results are often not as clear as expected. For
example in an area with low STH prevalence and relatively low
compliance to MDA in Sri Lanka, it was concluded that four
rounds of MDA had little effect on STH infections in school
children [25]. In India only a single round of MDA showed
reduction of STH infections in school children at several time
points following treatment [26]. Prior studies have shown that
individuals become rapidly re-infected with STH and that re-
infection rates for Ascaris are the highest [27]. Since rapid re-
infections are a major problem for STH, evaluation of the effect of
MDA on STH should be done probably more frequently or closer
to the next treatment date. Modeling studies have predicted that
LF elimination can be achieved more rapidly by employing twice
yearly MDA, while reducing the overall program costs [28]. Twice
yearly MDA could help to prevent re-infection of STH and
should, therefore, show a stronger benefit for STH reduction. On
Figure 4. Prevalence rates with 95% confidence intervals for STH infections in Mainang village before and after MDA with DEC/
albendazole. The first round of MDA was performed just after this the 2002 survey. The 2007 STH data were from a survey that was performed just
prior to the last (6th) round of MDA. A Ascaris lumbricoides. B Hookworm (mainly Necator americanus) and C Trichiuris trichiura.
doi:10.1371/journal.pntd.0002586.g004
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Figure 5. Geometric mean egg counts per gram of stool (as assessed by a single Kato-Katz smear) for individuals with STH
infections in Mainang village in 2002 (before the 1st round of MDA, black bars) and in 2009 (22 months after the 6th and final round
of DEC/albendazole MDA, gray bars). The data are shown by age group. Error bars indicate the 75 percentiles, and the broken lines represent
thresholds for light and moderate infection intensities according to WHO guidelines. The number on top of each column represents the number of
positive individuals tested per age group. A Ascaris lumbricoides. B Hookworm (mainly Necator americanus).
doi:10.1371/journal.pntd.0002586.g005
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the other hand the present study also shows an effect of MDA on
STH using annual follow-ups.
Unfortunately, when MDA for LF was stopped in 2008, the
district government had no school- or community-based STH
deworming program in place to help preserve the beneficial effect
that MDA had had on STH. While it was relatively easy for the
district government to obtain external funds for LF elimination
(since that was an attractive new public health program), it was not
possible for the district to obtain support for routine de-worming.
At the time the discussion about integration of control and
elimination programs for the different NTDs was just starting.
Taken together our study has provided evidence that Anopheles-
transmitted B. timori can be eliminated by MDA alone, and that
antibody prevalence assessed by Brugia Rapid in the population
decreases after MDA but at a slower pace than MF prevalence.
Our data also show that MDA for LF with DEC plus albendazole
is a mass de-worming program that reduces prevalence rates for
hookworm and Trichuris and also reduces STH infection intensi-
ties. However, the study also showed STH rates rebounded
quickly after MDA was discontinued. Further work is needed to
develop strategies and guidelines for controlling STH in commu-
nities following suspension of MDA for LF.
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